Locations
England, UK · Oxford, UK · headington, oxford, uk
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Seed
founded in
2021
Alethiomics is a pre-clinical biotech company focused on advancing its multi-omics target discovery pipeline specifically for blood cancer. By leveraging single-cell multi-omic technology, the company aims to uncover new biological insights that can lead to the development of life-changing treatments for patients. Their innovative approach differentiates them in the biotech space, targeting a critical area of unmet medical need. The company has gained recognition in the scientific community, as evidenced by their participation in significant events like the ASH plenary, indicating a strong market position and traction in the field of blood cancer research.
Something looks off?